Kataoka N - Search Results

1

Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study.

Yoshimura A, Takeda T, Kataoka N, Tanimura K, Fukui M, Chihara Y, Takei S, Kawachi H, Nakanishi K, Yamanaka Y, Tamiya N, Honda R, Okura N, Yamada T, Uryu K, Murai J, Shiotsu S, Yoshioka H, Yamada T, Kurata T, Takayama K. Yoshimura A, et al. Among authors: kataoka n. Front Oncol. 2024 Jan 26;14:1303543. doi: 10.3389/fonc.2024.1303543. eCollection 2024. Front Oncol. 2024. PMID: 38344209 Free PMC article.

2

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer.

Kataoka N, Kunimatsu Y, Tachibana Y, Sugimoto T, Sato I, Tani N, Ogura Y, Hirose K, Takeda T. Kataoka N, et al. Thorac Cancer. 2020 Sep;11(9):2740-2742. doi: 10.1111/1759-7714.13588. Epub 2020 Jul 24. Thorac Cancer. 2020. PMID: 32706170 Free PMC article.

3

Osimertinib-Associated Toxic Epidermal Necrolysis in a Lung Cancer Patient Harboring an EGFR Mutation-A Case Report and a Review of the Literature.

Sato I, Mizuno H, Kataoka N, Kunimatsu Y, Tachibana Y, Sugimoto T, Tani N, Ogura Y, Hirose K, Takeda T. Sato I, et al. Among authors: kataoka n. Medicina (Kaunas). 2020 Aug 11;56(8):403. doi: 10.3390/medicina56080403. Medicina (Kaunas). 2020. PMID: 32796633 Free PMC article. Review.

4

Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer.

Ogura Y, Kataoka N, Kunimatsu Y, Tachibana Y, Sugimoto T, Tani N, Sato I, Hirose K, Kato D, Takeda T. Ogura Y, et al. Among authors: kataoka n. Thorac Cancer. 2021 Jan;12(1):97-105. doi: 10.1111/1759-7714.13720. Epub 2020 Oct 30. Thorac Cancer. 2021. PMID: 33124197 Free PMC article.

5

Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study.

Tani N, Kataoka N, Kunimatsu Y, Tachibana Y, Sugimoto T, Sato I, Ogura Y, Hirose K, Takeda T. Tani N, et al. Among authors: kataoka n. Multidiscip Respir Med. 2021 Mar 17;16(1):736. doi: 10.4081/mrm.2021.736. eCollection 2021 Jan 15. Multidiscip Respir Med. 2021. PMID: 33815789 Free PMC article.

6

Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report.

Kataoka N, Kunimatsu Y, Tsutsumi R, Tani N, Sato I, Tanimura M, Nakano T, Tanimura K, Kato D, Takeda T. Kataoka N, et al. Medicina (Kaunas). 2021 May 29;57(6):547. doi: 10.3390/medicina57060547. Medicina (Kaunas). 2021. PMID: 34072448 Free PMC article.

7

The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy: A Retrospective Cohort Study.

Tanimura K, Yamada T, Omura A, Shiotsu S, Kataoka N, Takeda T, Taniguchi R, Yamada T, Takeuchi M, Chihara Y, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Takayama K. Tanimura K, et al. Among authors: kataoka n. Front Oncol. 2021 May 28;11:663612. doi: 10.3389/fonc.2021.663612. eCollection 2021. Front Oncol. 2021. PMID: 34123822 Free PMC article.

8

Nasogastric administration of osimertinib suspension for an epidermal growth factor receptor-mutated lung cancer causing an esophageal stricture: case report.

Tani N, Takatsuka S, Kataoka N, Kunimatsu Y, Tsutsumi R, Sato I, Tanimura M, Nakano T, Tanimura K, Kato D, Takeda T. Tani N, et al. Among authors: kataoka n. Ann Palliat Med. 2022 Apr;11(4):1542-1545. doi: 10.21037/apm-21-940. Epub 2021 Jul 5. Ann Palliat Med. 2022. PMID: 34263613 Free article.

9

Entrectinib for ROS1-rearranged non-small cell lung cancer after crizotinib-induced interstitial lung disease: A case report.

Tanimura M, Kataoka N, Kunimatsu Y, Tsutsumi R, Sato I, Nakano T, Tanimura K, Takeda T. Tanimura M, et al. Among authors: kataoka n. Respirol Case Rep. 2021 Oct 4;9(11):e0857. doi: 10.1002/rcr2.857. eCollection 2021 Nov. Respirol Case Rep. 2021. PMID: 34631105 Free PMC article.

10

Atezolizumab in combination with carboplatin plus nab-paclitaxel for managing combined large-cell neuroendocrine carcinoma: A case report.

Tsutsumi R, Kataoka N, Kunimatsu Y, Sato I, Tanimura M, Nakano T, Tanimura K, Takeda T. Tsutsumi R, et al. Among authors: kataoka n. Respirol Case Rep. 2022 Jun 7;10(7):e0989. doi: 10.1002/rcr2.989. eCollection 2022 Jul. Respirol Case Rep. 2022. PMID: 35685848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

589 results

Search Page

Filters